GB0410379D0 - Treatment of cancer - Google Patents
Treatment of cancerInfo
- Publication number
- GB0410379D0 GB0410379D0 GB0410379A GB0410379A GB0410379D0 GB 0410379 D0 GB0410379 D0 GB 0410379D0 GB 0410379 A GB0410379 A GB 0410379A GB 0410379 A GB0410379 A GB 0410379A GB 0410379 D0 GB0410379 D0 GB 0410379D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0410379A GB0410379D0 (en) | 2004-05-11 | 2004-05-11 | Treatment of cancer |
PCT/GB2005/001765 WO2005107782A2 (en) | 2004-05-11 | 2005-05-10 | Use of a modulator of gene expression in the treatment of cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0410379A GB0410379D0 (en) | 2004-05-11 | 2004-05-11 | Treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0410379D0 true GB0410379D0 (en) | 2004-06-16 |
Family
ID=32526744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0410379A Ceased GB0410379D0 (en) | 2004-05-11 | 2004-05-11 | Treatment of cancer |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0410379D0 (en) |
WO (1) | WO2005107782A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170123607A (en) | 2014-12-11 | 2017-11-08 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Cell Necrosis Inhibitors and Related Methods |
CN111808958A (en) * | 2020-07-13 | 2020-10-23 | 青岛市市立医院 | PCR reagent for detecting apoptosis signal path and application thereof |
WO2024049971A2 (en) * | 2022-09-02 | 2024-03-07 | Baylor College Of Medicine | Modulation of b-cell translocation gene 1 (btg1) for use in adoptive cell therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5650316A (en) * | 1994-06-06 | 1997-07-22 | Research Development Foundation | Uses of triplex forming oligonucleotides for the treatment of human diseases |
AU2003256453A1 (en) * | 2002-07-03 | 2004-01-23 | The Trustees Of Columbia University In The City Of New York | Methods for identifying modulators of mda-7 mediated apoptosis |
-
2004
- 2004-05-11 GB GB0410379A patent/GB0410379D0/en not_active Ceased
-
2005
- 2005-05-10 WO PCT/GB2005/001765 patent/WO2005107782A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005107782A2 (en) | 2005-11-17 |
WO2005107782A3 (en) | 2006-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200800907B (en) | Treatment of cancer | |
IL227841A0 (en) | Dihydropteridinones for the treatment of cancer diseases | |
HK1204476A1 (en) | Compounds and methods for treatment of cancer | |
IL188430A0 (en) | Treatment of tumors | |
IL197315A0 (en) | Treatment of cancer | |
IL179129A0 (en) | Kit for treatment of cancer | |
EP1838330A4 (en) | Treatment of solid cancers | |
HK1117780A1 (en) | Compounds and methods for the treatment of cancer | |
EP1830847A4 (en) | Treatment for cancer | |
GB0428187D0 (en) | Cancer treatment | |
GB0413346D0 (en) | Treating cancer | |
IL187792A0 (en) | 4-anilino-3-quinolinecarbonitriles for the treatment of cancer | |
GB0426196D0 (en) | Methods of treatment | |
ZA200805522B (en) | Dioxoiane dérivates for the treatment of cancer | |
GB0329416D0 (en) | Treatment of cancer | |
GB0520067D0 (en) | Treatment of cancer | |
GB0410379D0 (en) | Treatment of cancer | |
IL180709A0 (en) | Treatment of tumours | |
GB0423273D0 (en) | Treatment of cancer | |
GB0404675D0 (en) | Cancer treatment | |
IL180460A0 (en) | Treatment of cancer | |
GB0421734D0 (en) | Treatment of cancer | |
ZA200700845B (en) | Treatment of cancer | |
GB0422225D0 (en) | Treatment of cancer | |
GB0420845D0 (en) | Treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |